Connecticut · 2025 Regular Session · Bill
HB 6062: AN ACT PROHIBITING DIRECT-TO-CONSUMER PRESCRIPTION DRUG ADVERTISEMENTS.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 6062 is a bill introduced in the Connecticut House on January 22, 2025. According to its official title, it concerns: AN ACT PROHIBITING DIRECT-TO-CONSUMER PRESCRIPTION DRUG ADVERTISEMENTS. Most recent recorded action (April 29, 2025): REF. BY HOUSE TO COMMITTEE ON Appropriations.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| No sponsor recorded in source data. | ||||
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REF. BY HOUSE TO COMMITTEE ON Appropriations
- FILE NO. 589
- HOUSE CALENDAR NUMBER 363
- FAV. RPT., TABLED FOR HOUSE CALENDAR
- RPTD. OUT OF LCO
- REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 04/07/25
- FILED WITH LCO
- Joint Favorable
- PUBLIC HEARING 0219
- REF. TO JOINT COMM. ON General Law
- DRAFTED BY COMMITTEE
- Vote to Draft
Showing 12 most recent of 13 actions. Full history